The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Research Report 2025
Synopsis
PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.
The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications.The significant R&D in prevailing class of therapeutics has given rise to targeted therapies.
This report aims to provide a comprehensive presentation of the global market for Phosphoinositide 3-Kinase (PI3K) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phosphoinositide 3-Kinase (PI3K) Inhibitors.
Report Scope
The Phosphoinositide 3-Kinase (PI3K) Inhibitors market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phosphoinositide 3-Kinase (PI3K) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Verastem Inc.
Segment by Type
CLL - Chronic Iymphocytic Ieukemia
FL - Follicular Iymphoma
Other Indications
Segment by Application
hospital
Research Institutes and Research Institutions
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.
The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications.The significant R&D in prevailing class of therapeutics has given rise to targeted therapies.
This report aims to provide a comprehensive presentation of the global market for Phosphoinositide 3-Kinase (PI3K) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phosphoinositide 3-Kinase (PI3K) Inhibitors.
Report Scope
The Phosphoinositide 3-Kinase (PI3K) Inhibitors market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Phosphoinositide 3-Kinase (PI3K) Inhibitors companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Verastem Inc.
Segment by Type
CLL - Chronic Iymphocytic Ieukemia
FL - Follicular Iymphoma
Other Indications
Segment by Application
hospital
Research Institutes and Research Institutions
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phosphoinositide 3-Kinase (PI3K) Inhibitors companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CLL - Chronic Iymphocytic Ieukemia
1.2.3 FL - Follicular Iymphoma
1.2.4 Other Indications
1.3 Market by Application
1.3.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Perspective (2019-2030)
2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Region
2.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Region (2019-2024)
2.2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Region (2025-2030)
2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Dynamics
2.3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Trends
2.3.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers
2.3.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Challenges
2.3.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Revenue
3.1.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Revenue (2019-2024)
3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Players (2019-2024)
3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue
3.4 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio
3.4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2023
3.5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Area Served
3.6 Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Solution and Service
3.7 Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Type
4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Type (2019-2024)
4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2025-2030)
5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Application
5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Application (2019-2024)
5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
6.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
6.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
7.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
7.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
8.2 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2019-2024)
8.4 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
9.2 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
9.4 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2019-2030)
10.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2019-2024)
10.4 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Detail
11.2.2 Gilead Sciences Inc. Business Overview
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.2.5 Gilead Sciences Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.3.5 Novartis AG Recent Development
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Detail
11.4.2 TG Therapeutics Inc. Business Overview
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.4.5 TG Therapeutics Inc. Recent Development
11.5 Verastem Inc.
11.5.1 Verastem Inc. Company Detail
11.5.2 Verastem Inc. Business Overview
11.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.5.4 Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2019-2024)
11.5.5 Verastem Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
